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Rare Coexistence Of Benign Renal Oncocytoma And Renal Cell Carcinoma 




The coexistence of two tumors in a single person is not common. Finding 
two tumors in a single organ is rare.  We are reporting a 65 years old male 
who presented with a long history of left loin pain. Clinical examination 
was unremarkable apart from hypertension. The histopathology of intra-
abdominal mass seen on exploration of abdomen revealed oncocytoma and 
renal cell carcinoma. 
 





 65 years old barber male, presented with chronic left loin pain for the last 2 years, which 
was dull aching, not radiating and without associated urinary symptoms. There was no 
fever, bone ache or other systemic symptoms. He has no previous medical history. 
General examination revealed healthy looking patient, not pale, jaundice or febrile. His pulse rate 
was 88 beats/m. BP 200/110 mmHg. Cardiovascular and Chest examination revealed no 
abnormalities. Abdomen was soft, not distended, no palpable masses apart from slight fullness in 
the left renal triangle, and normal per rectum examination. 
Investigations: 
 
Complete blood count, urine analysis, blood 
urea, serum creatinine, sodium and potassium 
were normal. KUB film of the abdomen 
showed mildly increased left renal shadow at 
the lower pole. Ultrasound abdomen and 
pelvis revealed left renal solid mass. Contrast 
enhanced CT-Scan abdomen showed left 
renal solid mass with no vascular or 
lymphatic invasion and no adjacent organ 
involvement  
[Fig1]. IVU showed distorted left lower 
calyceal system, with a normal left renal 
pelvis. Isotope renal scintigraphy 
demonstrated poor functioning left kidney and 
well functioning right one. 
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Fig.1 CT-Scan showing lower pole left renal 
mass. 
 
Diagnosis and Management: 
   Diagnosis of left renal mass was made. His 
elevated blood pressure was controlled 
conjointly with medical department following 
oral amilodepine once per day. Following 
informed consent patient was prepared for 
surgery.  
Operative Findings and procedure: Under 
well monitored general anesthesia via endo-
tracheal tube, the abdominal cavity was 
A 
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approached through left transverse subcostal 
incision with good haemostasis using unipolar 
diathermy.  
The spleen showed multiple small nodules 
covered with whitish hard material and easily 
bleed on touch. Splenectomy was done on the 








Fig 3. The spleen. 
 
The peritoneal fluid was clear, there was no 
evidence of hepatic, lymphatic or peritoneal 
involvement.  
Then left renal artery and vein were identified 
and ligated in continuity before mobilization 
of the tumor, followed by removal of the left 
kidney [Fig 4] with its perinephric fat and 
Girota fascia, but left suprarenal gland was 
not removed.  
  He was discharged on the 6th postoperative 
day and the stitches were removed on the 10th 




Fig 4. The left kidney. 
Histopathological Report: 
The renal mass composed of two tumors, the 
major tumor is an oncocytoma. This was 
based on the gross finding of a scar and the 
brown tumor with no necrosis or hemorrhage. 
The small tumor was a renal cell carcinoma. 
This was based on the alveolar arrangement, 
lack of granular cytoplasm and the presence 
of clear cells. There was no vascular, capsular 
or lymphatic invasion. The carcinoma might 
have been embedded in the oncocytoma. This 
may explain the long history in this patient; 
presumably the benign oncocytoma had 
preceded the renal cell carcinoma. 
 The spleen measured 9 cm in length and 
showed sugar icing on the capsule indicative 
of a previous perisplenitis. This area showing 
fibrosis was the capsule. The splenic 
parenchyma was normal. 
   
Discussion: 
 Our patient had presented with left flank pain 
and hypertension. The histopathology oh his 
abdominal mass confirmed the coexistence of 
oncocytoma and renal cell carcinoma. Most 
common presenting symptoms of renal cell 
carcinoma are hematuria (40%), flank pain 
(40%) and palpable mass in the flank or 
abdomen (25%). Other clinical presentation 
range from weight loss (33%), fever (20%), 
hypertension (20%), hypercalcaemia (5%), 
night sweats, malaise and left sided varicocele 
(2%). Ten per cent of the patients present with 
the classic triad of flank pain, hematuria, and 
flank mass which is uncommon and it is 
indicative of advanced disease. Asymptomatic 
group account for 25-30% of patients, and 
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their renal cell carcinomas are found 
incidentally. Renal cell carcinoma may 
remain clinically hidden for most of its 
course1. Finding two tumors at the same site –
as in our patient- is rare. However, multiple 
ones may coexist at different sites. 
Multifocality of renal oncocytoma and its 
coexistence with renal cell carcinoma was 
reviewed earlier. Oncocytoma was found to 
be unilateral in 95%, bilateral in 5%. 
Coexistence of renal cell   carcinoma and 
oncocytoma were found in 14(10%) of 
patients, with overall multifocality, 
bilateralism and metachronous reaching 4 to 
6%2. 
The occurrence of contralateral metacronous 
renal oncocytoma in 52 years old man after 
10 years following nephrectomy for renal cell 
carcinoma, was reported before. The 
contralateral oncocytoma was asymptomatic 
and discovered during routine follow up. This 
long history is similar to our patient who 
presented with a 2 years history of left loin 
pain. Presumably the benign oncocytoma had 
preceded the renal cell carcinoma3. 
Siemer et al, reported 3.5% incidence of 
bilateral renal cell carcinoma in Germany. 
They found 66 patients with bilateral cell 
carcinoma. Synchronous tumors were 29 and 
37 were asynchronous tumors. Clear renal cell 
carcinoma ranking number one, representing 
70%, while chromophil renal cell carcinoma 
representing 36%4. 
A similar to our reported case is a 45 year old 
female, seen elsewhere. She presented with 
left renal mass, her sonographic, CT scan and 
renal angiographic features showed classical 
spoke-wheel appearance, and was treated by 
left radical nephrectomy. The 
histopathological diagnosis was oncocytoma 
in the upper pole and renal cell carcinoma in 
the lower pole of the same kidney. While our 
case showed renal cell carcinoma embedded 
in the oncocytoma on the same lower pole5.  
    Lich MR described coexistence of 
oncocytoma and renal adenoma; both of them 
are difficult to differentiate from renal cell 
carcinoma6. In a report one rare case of renal 
cell carcinoma and contralateral metacronous 
oncocytoma in a 52-year-old male who had 
right radical nephrectomy for renal cell 
carcinoma was described. Ten-year follow-up 
revealed multiple lesions in the left kidney. 
Partial nephrectomy was performed, and the 
pathological study showed three 
oncocytomas3. 
The incidence of renal cell carcinoma being 
3% of adult malignancies, accounts for 
approximately 90-95% of neoplasms arising 
from the kidney, the most common age 
groups affected are those in the sixth to eighth 
decades of life, with male-to-female ratio 2:1. 
Our patient is 65 years old and is a male. 
However, more recent data suggest that this 
sex gap is narrowing 7, 8.    Lack of early 
warning signs, diverse clinical presentations, 
resistance to radiation and chemotherapy, and 
infrequent responses to immunotherapy 
agents such as interferon alpha and 
interleukin (IL)-2 are the characteristic 
features of renal cell carcinoma7. In patients 
failing immunotherapy there are new agents 
of anti-angiogenic effect, which act through 
targeting multiple receptor kinases, such as 
sorafenib and sunitinib7.   In the past, these 
tumors were believed to be derived from the 
adrenal gland; therefore, the term 
hypernephroma was used often. The proximal 
renal tubular epithelium is the tissue of origin 
for renal cell carcinoma. It occurs in a 
sporadic (nonhereditary) and a hereditary 
form, which are associated with structural 
alterations of the short arm of chromosome 3 
(3p) in both of them. There are 4 hereditary 
syndromes which are associated with renal 
cell carcinoma: (1) von Hippel-Lindau (VHL) 
syndrome, (2) hereditary papillary renal 
carcinoma (HPRC), (3) familial renal 
oncocytoma (FRO) associated with Birt-
Hogg-Dube syndrome (BHDS), and (4) 
hereditary renal carcinoma (HRC)1. Robson 
reported a 5-year survival rate in 1969 to be 
around 66% for stage I renal carcinoma, 64% 
for stage II, 42% for stage III, and only 11% 
for stage IV. Except for stage I, these survival 
statistics have remained essentially 
unchanged for several decades1,7, 9. 
   Other rare primary malignancies that have 
been reported to arise in the kidney include 
oncocytomas, lymphomas, soft tissue 
Ahmed M A Saeed et al.                                                   Renal Oncocytoma And Cell Carcinoma  
 
       © Sudan JMS Vol. 3, No.2, June 2008.                                                                         170 
sarcomas (eg, leimyosarcoma, liposarcoma), 
and carcinoids10-12. 
  Renal oncocytomas are uncommon benign 
tumors, which are believed to arise from the 
intercalated cells of the renal collecting 
tubules, and behave differently from renal cell 
carcinomas. They may coexist in rare genetic 
syndromes, and some specific chromosomal 
abnormalities were postulated to differentiate 
it from renal cell carcinoma13-16. Renal 
oncocytoma can be also differentiated from 
renal cell carcinoma preoperatively by CT 
examination, which shows central stellate scar 
within an otherwise homogeneous tumor on 
ultrasound and CT scan, and an angiographic 
spoked-wheel pattern, may occur in renal cell 
carcinomas. Cystic necrosis and calcification 
are rare in oncocytoma and more common in 
renal cell carcinoma13,17-20. These criteria, 
which are reliable only if the mass is 3 cm or 
larger, would have resulted in the correct 
diagnosis of oncocytoma in 16/18 cases13. 
Nephron-sparing surgery is rather adequate in 
oncocytoma, but when it coexists with renal 
cell carcinoma, invading the perirenal fat, 
showing rapid growth or when preoperative 
differentiation from renal cell carcinoma is 
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